Antimycotoxin composition
The invention relates to the use of a composition comprising at least one strain of Bacillus subtilis , for the degradation of mycotoxins.
1. A method for the treatment of animals suffering from a pathology related to the ingestion of at least one mycotoxin, or the prevention of said pathologies, the method comprising a step of administering to an animal in need thereof, a composition comprising or consisting essentially of
strain NOL03,
said strain being filed with the CNCM under number CNCM I-4607.
2. The method according to claim 1 , wherein said composition comprises said strain NOL03, and at least one of the following strains,
Strain NOL01, filed with the CNCM under number CNCM I-4606,
Strain NOL02, filed with the CNCM under number CNCM I-5043, and
Strain NOL04, filed with the CNCM under number CNCM I-4608.
3. The method according to claim 1 , wherein said pathologies are related to the ingestion of at least two mycotoxins with different structures.
4. The method according to claim 1 , where wherein said composition comprises
Strain NOL03 deposited with the CNCM under number CNCM I-4607,
Strain NOL01 deposited with the CNCM under number CNCM I-4606, and
Strain NOL02 deposited with the CNCM under number CNCM I-5043.
5. The method according to claim 1 , wherein said at least one mycotoxin is chosen from aflatoxins B1, B2, M1, G1 and G2, toxin T-2, toxin HT-2, deoxynivalenol (or nivalenol), zearalenone, a fumonisin B family mycotoxin, and ochratoxin A.
6. The method according to claim 5 , wherein said fumonisin B family mycotoxin is fumonisin B1.
7. The method according to claim 3 , wherein said at least two mycotoxins comprise deoxynivalenol (DON) and a fumonisin B family mycotoxin.
8. The method according to claim 4 , wherein said at least one mycotoxin is selected from deoxynivalenol (DON) and a fumonisin B family mycotoxin.
9. The method according to claim 8 , wherein said fumonisin B family mycotoxin is fumonisin B1.